ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Cemat A/s

Cemat A/s (0GB8)

0.44
0.00
(0.00%)
마감 23 1월 1:30AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
0.44
매수가
0.00
매도가
0.00
거래량
0.00
0.00 일간 변동폭 0.00
0.44 52주 범위 0.44
market_cap
전일 종가
0.44
개장가
-
최근 거래 시간
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
0.00
발행 주식
249,850,000
배당수익률
-
주가수익률
10.71
주당순이익(EPS)
0.04
매출
33.6M
순이익
10.28M

Cemat A/s 정보

섹터
Lessors Of Real Property,nec
산업
Minrls,earths-ground,treated
웹사이트
본부
Frederikssund, Dnk
설립됨
2016
Cemat A/s is listed in the Lessors Of Real Property sector of the 런던증권거래소 with ticker 0GB8. The last closing price for Cemat A/s was kr0.44. Over the last year, Cemat A/s shares have traded in a share price range of kr 0.44 to kr 0.44.

Cemat A/s currently has 249,850,000 shares in issue. The market capitalisation of Cemat A/s is kr109.93 million. Cemat A/s has a price to earnings ratio (PE ratio) of 10.71.

0GB8 최신 뉴스

No. 12/2024 - CeMat A/S acquires right of perpetual usufruct to land plot in Bielany, Warsaw

No. 12/2024 - CeMat A/S acquires right of perpetual usufruct to land plot in Bielany, Warsaw Nasdaq Copenhagen                                                                                   ...

No. 11/2024 - Managers' transactions

No. 11/2024 - Managers' transactions Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen...

No. 10/2024 - Managers' transactions

No. 10/2024 - Managers' transactions Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen...

No. 9/2024 - Managers' transactions

No. 9/2024 - Managers' transactions Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen, 3...

No. 8/2024 - Managers' transactions

No. 8/2024 - Managers' transactions Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen...

No. 7/2024 - Interim report, H1 2024

No. 7/2024 - Interim report, H1 2024 Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen, 29...

No. 6/2024 - Course of the annual general meeting

No. 6/2024 - Course of the annual general meeting Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K   ...

No. 5/2024 - Managers' transactions

No. 5/2024 - Managers' transactions Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen...

No. 4/2024 - Notice to convene annual general meeting

No. 4/2024 - Notice to convene annual general meeting Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K   ...

Nr. 3/2024 - Managers' transactions

Nr. 3/2024 - Managers' transactions Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K    Copenhagen...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1000.440.440.4400DE
4000.440.440.4400DE
12000.440.440.4400DE
26000.440.440.4400DE
52000.440.440.4400DE
156000.440.440.4400DE
260000.440.440.4400DE

0GB8 - Frequently Asked Questions (FAQ)

What is the current Cemat A/s share price?
The current share price of Cemat A/s is kr 0.44
How many Cemat A/s shares are in issue?
Cemat A/s has 249,850,000 shares in issue
What is the market cap of Cemat A/s?
The market capitalisation of Cemat A/s is DKK 109.93M
What is the 1 year trading range for Cemat A/s share price?
Cemat A/s has traded in the range of kr 0.44 to kr 0.44 during the past year
What is the PE ratio of Cemat A/s?
The price to earnings ratio of Cemat A/s is 10.71
What is the cash to sales ratio of Cemat A/s?
The cash to sales ratio of Cemat A/s is 3.27
What is the reporting currency for Cemat A/s?
Cemat A/s reports financial results in DKK
What is the latest annual turnover for Cemat A/s?
The latest annual turnover of Cemat A/s is DKK 33.6M
What is the latest annual profit for Cemat A/s?
The latest annual profit of Cemat A/s is DKK 10.28M
What is the registered address of Cemat A/s?
The registered address for Cemat A/s is R��DHUSPLADSEN 4, 1550 K��BENHAVN V, FREDERIKSSUND, DK-3600
What is the Cemat A/s website address?
The website address for Cemat A/s is www.en.cemat.dk
Which industry sector does Cemat A/s operate in?
Cemat A/s operates in the MINRLS,EARTHS-GROUND,TREATED sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M
Hardazoak Hardazoak 1 분 전
Current Aabbg works fine, wallet works fine. New aabb wallet 2.0 with AI and moonpay exchange integrated coming. Stop with the lies gitreal, only you are believing your own lies.
AABB
KPIFF-LDDFF KPIFF-LDDFF 2 분 전
KPIFF
wadegarret wadegarret 2 분 전
Novice- AI stocks have mostly done their thing

I don't believe Stargate will add all that much to boost valuations further. I mean NVDA already sells for over a 30 something PE going forward, CRDO sells for an 85 PE going forward, CRWD sells for around an 80 PE going forward, PLTR
AES CRDO CRWD
PEACHMAN PEACHMAN 2 분 전
The exact opposite of what you say is true.LOLOLOLOL!!!!! I OWN you, kitty. Heart, mind, body and soul!! You fall into traps, you copy verbatim my posts. Have you ever had an independent thought in your life?

https://investorshub.advfn.com/uimage/uploads/2025/1/22/sdlmono_panther.pn
IFUS
pinhigh pinhigh 3 분 전
Well done video gimmee! RRX!
BIEL
Orange Cassidy Orange Cassidy 5 분 전
The Jared "whisperer" is still here in emoji form on every post. He has not gone anywhere. As it stands the mills are abandoned and this is still a sham. "Whats not to like?"
NBRI
bas2020 bas2020 5 분 전
Any shorting after approval will be total manipulation by the corrupt cabal... your bosses. Hopefully, we'll have MTD denial prior with a cease and desist order to go with it... to cut ya all off at the knees. 💥
NWBO
hssbwwmp hssbwwmp 5 분 전
Yes, I've seen them cite those factors in their reports as well as being flexible to adapt to them. So, it would seem that if AXXA was still able to grow revenue and reduce debt despite those factors, then the PPS should not have continued this long downtrend, correct? Something still is not comp
AXXA
RichieBoy RichieBoy 6 분 전
Minute 28 - Minute 40 is on AI

Keep in mind this is acutely political. So you'll be left wondering about this side of AI and oh that part of AI why aren't they important. They are important of course, but never before to date will you have seen such intense focus on this one facet.
AFFU
boarddork boarddork 7 분 전
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 7 분 전
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 8 분 전
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 9 분 전
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 10 분 전
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 10 분 전
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 13 분 전
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 13 분 전
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 14 분 전
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 15 분 전
Whats 305
RNVA
theorysuit theorysuit 16 분 전
You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO
NWBO
WHITTENHALLJR WHITTENHALLJR 16 분 전
Yes I bet it 2x better then before strap in stock-nuts
CLHI

최근 히스토리

Delayed Upgrade Clock